Leading with strategy, our RCO model delivers bespoke / custom solutions that deliver results. Our fit-for purpose global solutions span across the full product lifecycle.
Learn more about our RCO model.
Explore All RCO Solutions
Explore All Services
Explore all Therapeutic Areas
Insights & News
June 17, 2014
CEO Matthew Weinberg writes for Tobacco Reporter Magazine encouraging stakeholders to take advantage of the opportunity to respond to FDA e-cigarette regulations.
For more information on The Weinberg Group’s independent clinical auditing services, please contact Jeff Antos at email@example.com or 202.280.0815.
In this article CEO Matthew Weinberg discusses the downsides to self-auditing good clinical practice and the need smaller, more proactive audits, on the other hand, can provide a more intelligent...
April 23 - The Weinberg Group CEO, Matthew Weinberg, presented today at FDA’s hearing titled “Modernizing the Regulation of Clinical Trials and Approaches to Good Clinical Practice.” Mr. Weinberg...